Is a complete ETR/JNJ research report available?

No complete published report is available for etr/JNJ (ETR/JNJ) on this page. Market-directory data, when present, is not a substitute for a validated stock analysis.

etr/JNJ stock profile: metrics, valuation and analysis

Market cap	552B
Revenue (ttm)	85.9B
Net income (ttm)	18.4B
EPS (ttm)	€7.56
P/E (trailing)	29.9x
P/E (forward)	22.7x
Dividend	€4.53 (1.96%)
Volume	996
Beta	0.23

All ETR/JNJ indicators

Market & fundamental data

Available fields

251

Groups with data

Currency

USD

Showing 251 of 251 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	United States
Country code	DE
Employees	138,200
Employees Change	6,200%
Employees Change Percent	4.7
Enterprise value	EUR 576.3B
Exchange	Deutsche Börse Xetra
Financial currency	USD
First seen	2026-05-10
Industry	Drug Manufacturers - General
Isin	US4781601046
Last refreshed	2026-09-12
Market cap	EUR 552B
Price	EUR 230
Price currency	EUR
Rev Per Employee	621,303.53x
Sector	Healthcare
Sector PE	37.53
Sector PE Fwd	14.15
Sic	2834
Symbol	etr/JNJ
Website	https://www.jnj.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	3.34%
EV Earnings	31.25x
EV/EBIT	24.71x
EV/EBITDA	19.11x
EV/FCF	29.55x
EV/Sales	6.84x
FCF yield	3.53%
Forward P/E	22.73x
P/B ratio	7.41x
P/E ratio	29.93x
P/S ratio	6.43x
PE Ratio10 Y	46x
PE Ratio3 Y	18.31x
PE Ratio5 Y	21.36x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	27.69%
EBITDA Margin	35.61%
FCF margin	23.1%
Gross margin	68.14%
Gross Profit	EUR 58.5B
Gross Profit Growth	7.63%
Gross Profit Growth Q	7.22%
Gross Profit Growth3 Y	5.43%
Gross Profit Growth5 Y	2.23%
Net Income	EUR 18.4B
Net Income Growth	-7.17%
Net Income Growth Q	-0.05%
Net Income Growth Qo Q	5.71%
Net Income Growth Quarters	1%
Net Income Growth Years	1%
Net Income Growth3 Y	17.24%
Net Income Growth5 Y	3.44%
Pretax Margin	25.73%
Profit Margin	21.48%
Profit Per Employee	EUR 133,468
Profitable Quarters	EUR 13
Profitable Years	41
ROA	8.59
Roa5y	8.04
ROCE	18.55
ROE	25.74
Roe5y	24.21
ROIC	19.92
Roic5y	23.67

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr10y	11.03%
Cagr15y	14.42%
Cagr1y	57.4%
Cagr20y	11.12%
Cagr3y	18.72%
Cagr5y	13.27%
Div CAGR10	4.95%
Div CAGR3	1.37%
Div CAGR5	5.52%
EPS Growth	-7.58
EPS Growth Q	-0.87
EPS Growth Qo Q	6.07
EPS Growth Years	1
EPS Growth3 Y	20.48
EPS Growth5 Y	5.34
FCF Growth	19.92%
FCF Growth Q	157.32%
FCF Growth Qo Q	397.95%
FCF Growth3 Y	15.21%
FCF Growth5 Y	-0.29%
OCF Growth	19.89%
OCF Growth Q	122.18%
OCF Growth Qo Q	242.72%
OCF Growth10 Y	4.38%
OCF Growth3 Y	13.12%
OCF Growth5 Y	1.12%
Revenue Growth	8.06x
Revenue Growth Q	6.6x
Revenue Growth Qo Q	5.19x
Revenue Growth Quarters	8x
Revenue Growth Years	2x
Revenue Growth3 Y	5.95x
Revenue Growth5 Y	1.89x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	EUR 0.5
Assets	EUR 176.3B
Cash	EUR 18.2B
Current Assets	EUR 51.5B
Current Liabilities	EUR 47.3B
Debt	EUR 43B
Debt EBITDA	EUR 1.4
Debt Equity	EUR 0.58
Debt FCF	EUR 2.2
Equity	EUR 74.5B
Interest Coverage	26.8
Liabilities	EUR 101.8B
Long Term Assets	EUR 124.8B
Long Term Liabilities	EUR 54.5B
Net Cash	EUR -24.8B
Net Cash By Market Cap	EUR -4.49
Net Debt EBITDA	EUR 0.81
Net Debt Equity	EUR 0.33
Net Debt FCF	EUR 1.27
Tangible Book Value	EUR -10.3B
Tangible Book Value Per Share	EUR -4.27
WACC	5.25

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	1.09
Inventory Turnover	2.19
Net Working Capital	EUR -3.7B
Quick ratio	0.73
Working Capital	EUR 4.3B
Working Capital Turnover	EUR 33.04

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-0.53%
Dividend Growth	-2%
Dividend Growth Years	14%
Dividend per share	EUR 4.53
Dividend Years	29
Dividend Yield	1.96%
Ex Div Date	2026-08-25
Last Dividend	EUR 1.15
Payout Frequency	Quarterly
Payout Ratio	59.99%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
10Y total return	184.62%
1Y total return	57.35%
200-day SMA	204.7
3Y total return	67.33%
50-day SMA	228.4
50-day SMA vs 200-day SMA	50over200
5Y total return	86.48%
All Time High	241.9
All Time High Change	-4.98%
All Time High Date	2026-09-02
All Time Low	36.35
All Time Low Change	532.32%
All Time Low Date	2009-03-19
ATR	4.17
Beta	0.23
Ch YTD	30.08
High	232.5
High52	241.9
High52 Date	2026-09-02
High52ch	-4.98%
Low	229.9
Low52	147
Low52 Date	2025-09-17
Low52ch	56.38%
Ma50ch	0.65%
Price vs 200-day SMA	12.29%
RSI	48.94
RSI Monthly	74.49
RSI Weekly	59.9
Sharpe ratio	2.05x
Sharpe Ratio3y	0.79x
Sharpe Ratio5y	0.59x
Sortino ratio	3.57
Sortino Ratio3y	1.48
Sortino Ratio5y	1.2
Total Return	1.43%
Tr YTD	32.18
Tr15y	654.75%
Tr1m	2.57%
Tr1w	-3.36%
Tr3m	11.46%

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	2,405,987,057%
Net Borrowing	-1,355,372,112
Shares Insiders	0.04%
Shares Institutions	76.38%
Shares Qo Q	-0.21%
Shares Yo Y	0.53%
Short Ratio	2.81

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	EUR 18.3B
Adjusted OCF	22,966,899,200
Average Volume	2,229.9x
Bv Per Share	30.94
CAPEX	EUR -4.7B
Ch10y	116.7
Ch15y	393.1
Ch1m	2.07
Ch1w	-3.36
Ch1y	53.87
Ch20y	362
Ch3m	10.91
Ch3y	53.64
Ch5y	62.14
Ch6m	10
Change	0.17%
Change From Open	-0.28
Close	229.5
Days Gap	0.46
Depreciation Amortization	6,682,881,196
Dollar Volume	228,930.6
Earnings Date	2026-10-13
EBIT	EUR 23.8B
EBITDA	EUR 30.6B
EPS	EUR 7.56
F Score	7
FCF	EUR 19.5B
FCF EV Yield	3.38x
Financing CF	-16,258,502,400
Fiscal Year End	December
Founded	1,886
Goodwill	41,798,399,884
Graham Number	73.21729
Graham Upside	-68.15
Income Tax	EUR 3.6B
Investing CF	-6,292,793,600
Is Primary Listing	0
Last Earnings Date	2026-07-15
Last Report Date	2026-06-28
Lynch Fair Value	EUR 38.4
Lynch Upside	-83.29
Ma150	211.9
Ma150ch	8.46%
Ma20	232.5
Ma20ch	-1.12%
Net CF	1,617,696,000
Next Earnings Date	2026-10-13
Open	230.5
P FCF Ratio	28.3
P FCF Ratio SBC	30.22
P OCF Ratio	22.8
P OCF Ratio SBC	24.04
Payment Date	2026-09-08
Position In Range	0
Ppne	20,332,306,072
Price Date	2026-09-11
Price EBITDA	EUR 18.05
Relative Volume	0.44x
Revenue	85,864,147,200x
SBC By Revenue	1.44x
Share Based Comp	1,239,795,200
Tax By Revenue	4.25x
Tax Rate	16.51%
Tr20y	723.88%
Tr6m	11.19%
Volume	996
Z Score	4.74

ETR/JNJ (ETR/JNJ)

Price

Financial snapshot

Fair-value bridge

Latest news · ETR/JNJ

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All ETR/JNJ indicators

Profile and market data

Valuation

Profitability

Growth

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Ownership and float

Other indicators

Deeper analysis on ETR/JNJ

Frequently asked questions